WallStreetZenWallStreetZen

NASDAQ: INTS
Intensity Therapeutics Inc Stock Ownership - Who owns Intensity Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Intensity Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John M. WesolowskiPrincipal Accounting Officer2024-06-051,000$4.00
$4.00kBuy

1 of 1

INTS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when INTS insiders and whales buy or sell their stock.

INTS Shareholders

What type of owners hold Intensity Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lewis H. Bender13.17%2,000,000$1.27MInsider
Armistice Capital LLC7.42%1,126,868$717.81kInstitution
Sapient Capital LLC6.21%942,841$600.59kInstitution
Vanguard Group Inc1.38%208,886$133.06kInstitution
Brown Advisory Inc0.86%130,072$82.86kInstitution
Geode Capital Management LLC0.42%64,349$40.99kInstitution
Sigma Planning Corp0.36%54,837$34.93kInstitution
Blair William Co0.25%37,805$24.08kInstitution
One Charles Private Wealth Services LLC0.21%31,800$20.26kInstitution
Blackrock Inc0.15%22,252$14.17kInstitution

1 of 3

INTS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
INTS17.92%13.22%Net Buying
NEUP1.19%98.81%
CYCN11.83%88.17%Net SellingNet Buying
ACXP6.40%11.67%Net Buying
APRE3.38%96.62%Net BuyingNet Buying
View Top Biotech Stocks

Intensity Therapeutics Stock Ownership FAQ

Who owns Intensity Therapeutics?

Intensity Therapeutics (NASDAQ: INTS) is owned by 17.92% institutional shareholders, 13.22% Intensity Therapeutics insiders, and 68.86% retail investors. Lewis H. Bender is the largest individual Intensity Therapeutics shareholder, owning 2.00M shares representing 13.17% of the company. Lewis H. Bender's Intensity Therapeutics shares are currently valued at $1.20M.

If you're new to stock investing, here's how to buy Intensity Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.